Clinical Trials Directory

Trials / Completed

CompletedNCT06820944

Theobromine From Cocoa and Cardiovascular Risk Factors

Theobromine Consumption From Cocoa and Cardiovascular Risk Factors in Humans: Evidence for Health Claims

Status
Completed
Phase
N/A
Study type
Interventional
Enrollment
53 (actual)
Sponsor
Chiang Mai University · Academic / Other
Sex
Male
Age
35 Years – 70 Years
Healthy volunteers
Not accepted

Summary

The goal of this clinical trial is to examine whether consumption of dark chocolate affects blood pressure and a cardiovascular risk factor called trimethylamine N-oxide in Thai male participants with hypertension. The main questions it aims to answer are: Can consumption of dark chocolate lower blood pressure? Can consumption of dark chocolate lower blood trimethylamine N-oxide? Researchers will compare dark chocolate to white chocolate to see if the effects are due to theobromine (a key bioactive compound in dark chocolate). Participants will consume either 100 g 72% dark chocolate bar or 80 g white chocolate bar daily for 14 days, rest for 7 days, and then switch to the other type of chocolate.

Detailed description

This is a randomized cross-over trial conducted in Chiang Mai, Thailand. The goal of this clinical trial is to examine whether consumption of dark chocolate affects cardiovascular risk factors, with the primary outcomes being blood pressure and a cardiovascular risk factor called trimethylamine N-oxide. Participants are Thai males aged 35-70 years with hypertension who live in the Chiang Mai area. 42 Participants will consume either 100 g 72% dark chocolate bar (\~2.5 servings, providing \~900 mg theobromine) or 80 g white chocolate bar (\~2 servings, providing 0 mg theobromine) daily for 14 days. After a 7-day wash-out period, the participant will repeat the protocol with the other intervention.

Conditions

Interventions

TypeNameDescription
OTHERdark chocolateConsumption of 100 g/day of 72% dark chocolate bar for 14 days consecutively
OTHERwhite chocolateConsumption of 80 g/day of white chocolate bar for 14 days consecutively

Timeline

Start date
2025-02-15
Primary completion
2025-04-30
Completion
2025-04-30
First posted
2025-02-11
Last updated
2026-03-18

Locations

1 site across 1 country: Thailand

Source: ClinicalTrials.gov record NCT06820944. Inclusion in this directory is not an endorsement.